Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming ...
Experts explain how they work, and how they can be incorporated topically into your routine to make skin look healthier, ...
Case Study Highlights INDIBA 448 kHz Radiofrequency's Role in Visceral Fat Reduction and Prevention of Fat Accumulation ...
19h
Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) ---- Continuing enrollment ...
Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...
Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has entered into the Medicaid ...
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
A new high-level scientific Advisory Board has been established to accompany and support the research, clinical, and ...
Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback